c tirzepatide niacinamide is the dual-action one. Instead of working on a single hormone, it targets two — GLP-1 and GIP — which is why it tends to have a stronger effect on appetite Tirzepatide + Niacinamide Injection -

GLP-1s carry an FDA boxed warning for medullary thyroid cancer and should not be used by patients with a personal or family history of MTC or MEN2

Many studies have specifically addressed factors influencing patient preferences, as this aspect is critical in improving adherence and reducing clinical inertia

With tirzepatide, patients may notice redness, mild pain, itching, or small bumps at the injection site

The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota

Women of reproductive age are particularly vulnerable because they already lose iron through menstruation